B
Catalyst Pharmaceuticals, Inc. CPRX
$19.92 -$0.705-3.42% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 206.19% 203.07% 129.50% 130.18% -41.02%
Total Depreciation and Amortization 3.43% 5.86% 14.88% 53.82% 123.87%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -95.70% -99.69% -90.56% -86.56% 617.00%
Change in Net Operating Assets 513.81% 260.10% 182.83% 199.59% 120.24%
Cash from Operations 39.76% 63.91% 67.00% 75.41% 58.48%
Capital Expenditure 98.97% 99.02% 99.72% 77.49% 78.90%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- 97.60% -1,062.48%
Cash from Investing 99.72% 99.73% 99.81% 84.80% 19.17%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -88.34% -88.35% 5,434.20% 2,715.55% 1,503.37%
Repurchase of Common Stock -101.67% -55.99% 31.98% 11.10% 11.10%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 1.08% 2.21% -4.07% -4.00% -519.48%
Cash from Financing -98.18% -97.94% 1,395.62% 1,807.61% 2,029.20%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 40.73% 66.65% 336.33% 337.88% 712.94%